Introduction to GEP-NETs

While neuroendocrine tumours (NETs) can appear in most organs,¹ the gastrointestinal system, including the pancreas, is the most common primary location of NETs.² These tumours, described as gastroenteropancreatic neuroendocrine tumours (GEP-NETs), are commonly considered as slow-growing malignancies; however, some NETs are associated with rapid progression and poor prognosis.¹ Symptoms are often non-specific and subtle,^3,4 often leading to significant delays in diagnosis and a poor quality of life in these patients.⁴

Click on the following resources below and find out more information about GEP-NETs—their incidence, clinical behaviour and how they are diagnosed and treated.